Company Profiles

driven by the PitchBook Platform

Knopp Biosciences

Description

Developer of drugs intended to treat neurological, immunological and hematological disorders. The company's drugs is a dexpramipexole, a small molecule immunological therapeutic based on its preclinical and clinical activity in modulating white blood cells known as eosinophils enabling medical professional to treat Amyotrophic lateral sclerosis (ALS), Parkinson's disease and other neurological degenerative disorders.

2004

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$17.4M

Latest Deal Amount

$156M

Total Amount Raised

Description

Developer of drugs intended to treat neurological, immunological and hematological disorders. The company's drugs is a dexpramipexole, a small molecule immunological therapeutic based on its preclinical and clinical activity in modulating white blood cells known as eosinophils enabling medical professional to treat Amyotrophic lateral sclerosis (ALS), Parkinson's disease and other neurological degenerative disorders.

Website:

www.knoppbio.com

Formerly Known As

Knopp Neurosciences, Knopp Neurosciences Merger Sub

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Biotechnology
Drug Discovery

Primary Office

2100 Wharton Street Suite 615 Pittsburgh, PA 15203United States +1 (412) 488-1776
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Knopp Biosciences's full profile, request a free trial.

Knopp Biosciences Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Knopp Biosciences Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
BiogenPE-Backed CompanyMinority000 0000000 0000
Kramer Capital PartnerVenture CapitalMinority000 0000000 0000
LaunchCyteVenture CapitalMinority000 0000000 0000
National Institutes of HealthGovernment000 0000000 0000
Pittsburgh Life Sciences GreenhouseVenture CapitalMinority000 0000000 0000
Biogen PE-Backed Company
Kramer Capital Partner Venture Capital
LaunchCyte Venture Capital
National Institutes of Health Government
Pittsburgh Life Sciences Greenhouse Venture Capital

Knopp Biosciences Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Michael Bozik MDChief Executive Officer, Board Member & President
Gregory Hebrank MDExecutive Vice President, Corporate Operations & Finance & Board Member, Co-Founder
Frank Lucchino Jr.Vice President & General Counsel
Calman Prussin MDSenior Director, Clinical and Translational Medicine
Steven Dworetzky Ph.DVice President, Discovery Research
Michael Bozik MD Chief Executive Officer, Board Member & President
Gregory Hebrank MD Executive Vice President, Corporate Operations & Finance & Board Member, Co-Founder
Frank Lucchino Jr. Vice President & General Counsel
Calman Prussin MD Senior Director, Clinical and Translational Medicine
Steven Dworetzky Ph.D Vice President, Discovery Research

Knopp Biosciences Board Members (3)

NameRepresentingRoleSinceContact
Info
Benjamin GomezSelfBoard Member000 0000
Jeffrey McCormickSaturn PartnersFounder & Managing Partner000 0000
Thomas Petzinger Jr.SelfExecutive Vice President, Business Development and Public Affairs & Board Member000 0000
Benjamin Gomez Board Member Self
Jeffrey McCormick Founder & Managing Partner Saturn Partners
Thomas Petzinger Jr. Executive Vice President, Business Development and Public Affairs & Board Member Self
Request full access to PitchBook